Connor, Clark & Lunn Investment Management Ltd. Global Blood Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$22.3 - $37.39 $1.22 Million - $2.04 Million	54,486 Added 767.08%	61,589 $1.97 Million
Q1 2022 May 12, 2022	SELL	$25.68 - $35.59 $328,601 - $455,409	-12,796 Reduced 64.3%	7,103 $246,000
Q4 2021 Feb 10, 2022	SELL	$24.9 - $40.26 $2.71 Million - $4.38 Million	-108,780 Reduced 84.54%	19,899 $582,000
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $3.28 Million - $4.8 Million	128,679 New	128,679 $3.28 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account